Your browser doesn't support javascript.
loading
Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma.
Fuchs, Michael; Jacob, Anne Sophie; Kaul, Helen; Kobe, Carsten; Kuhnert, Georg; Pabst, Thomas; Greil, Richard; Bröckelmann, Paul J; Topp, Max S; Just, Marianne; Hertenstein, Bernd; Soekler, Martin; Vogelhuber, Martin; Zijlstra, Josée M; Keller, Ulrich Bernd; Krause, Stefan W; Dührsen, Ulrich; Meissner, Julia; Viardot, Andreas; Eich, Hans-Theodor; Baues, Christian; Diehl, Volker; Rosenwald, Andreas; Buehnen, Ina; von Tresckow, Bastian; Dietlein, Markus; Borchmann, Peter; Engert, Andreas; Eichenauer, Dennis A.
Afiliación
  • Fuchs M; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
  • Jacob AS; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
  • Kaul H; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
  • Kobe C; Department of Nuclear Medicine, University of Cologne, Cologne, Germany.
  • Kuhnert G; Nuclear Medicine Siegen I Kreuztal, Siegen, Germany.
  • Pabst T; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Greil R; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
  • Bröckelmann PJ; IIIrd Medical Department, Paracelcus Medical University and Salzburg Cancer Research Institute, Salzburg, Austria.
  • Topp MS; Salzburg Cancer Research Institute and AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie), Salzburg, Austria.
  • Just M; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
  • Hertenstein B; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.
  • Soekler M; Dres. med. Just/Düwel/Riesenberg/Steinke/Schäfer, Studiengesellschaft, Bielefeld, Germany.
  • Vogelhuber M; Department of Internal Medicine I, Klinikum Bremen Mitte, Bremen, Germany.
  • Zijlstra JM; Onkology, Spital Thun, Switzerland, formerly University of Tübingen, Tübingen, Germany.
  • Keller UB; Medizinische Klinik III, Universitätsklinik Regensburg, Regensburg, Germany.
  • Krause SW; Department of Hematology, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands.
  • Dührsen U; Department of Internal Medicine III, Klinikum "Rechts der Isar", Munich, Germany.
  • Meissner J; Department of Internal Medicine 5, Haematology/Oncology, Uniklinikum Erlangen, Erlangen, Germany.
  • Viardot A; Department of Haematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Eich HT; University of Heidelberg, Heidelberg, Germany.
  • Baues C; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
  • Diehl V; Department of Radiotherapy, University Hospital of Muenster, Muenster, Germany.
  • Rosenwald A; Department of Radiotherapy, University of Cologne, Cologne, Germany.
  • Buehnen I; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
  • von Tresckow B; Institute of Pathology, Julius Maximilian University of Würzburg and Comprehensive Cancer Center Mainfranken, Würzburg, Germany.
  • Dietlein M; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
  • Borchmann P; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
  • Engert A; Department of Haematology and Stem Cell Transplantation, West German Cancer Center and German Cancer Consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Eichenauer DA; Department of Nuclear Medicine, University of Cologne, Cologne, Germany.
Leukemia ; 38(1): 160-167, 2024 01.
Article en En | MEDLINE | ID: mdl-37845285
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Alemania